Benitec Biopharma reported cash from operations of -$3.73M and free cash flow of -$3.73M for the quarter ended Dec 2025, up 51.6% year over year. This cash flow statement covers 26 quarters of results from Sep 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -3.79M | -3.86M | -4.82M | -4.85M | -3.47M | -4.75M | -4.59M | -5.62M | -4.35M | -4.56M | -5.88M | -6.93M | -4.14M | -4.63M | -5.19M | -9.98M | -9.37M | -8.80M | -8.79M | -11.99M | ||||||
| Share-based Compensation | 0.05M | 1.01M | 0.79M | 0.08M | 0.30M | -0.05M | 0.07M | 0.13M | 0.09M | 0.09M | 0.19M | 0.45M | 0.43M | 3.14M | 0.40M | 13.45M | 5.18M | 37.80M | ||||||||
| Cash from Operations | -2.00M | -5.13M | -4.30M | -3.32M | -3.42M | -4.86M | -4.04M | -5.86M | -4.02M | -4.09M | -4.60M | -5.34M | -6.17M | -3.29M | -4.60M | -7.70M | -3.10M | -8.20M | -3.40M | -3.73M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.05M | 0.05M | 0.05M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.09M | 0.10M | 0.10M | 0.11M | ||||||
| Amortization of Deferred Charges | 0.05M | 0.05M | 0.05M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.09M | 0.10M | 0.10M | 0.11M | ||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.07M | 0.05M | 0.05M | 0.06M | 0.05M | 0.01M | 0.04M | 0.04M | 0.03M | 0.02M | 0.02M | 0.02M | 0.03M | 0.03M | 0.03M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Receivables | 0.01M | -0.01M | -0.05M | 0.05M | 0.18M | -0.23M | 0.03M | -0.03M | -0.12M | |||||||||||||||||
| Change in Account Payables | 1.64M | -1.16M | 0.29M | 0.85M | -0.63M | 0.58M | 0.50M | -0.55M | 0.63M | 0.78M | 0.57M | 1.14M | -2.31M | 1.54M | -0.32M | -0.66M | 3.84M | -5.24M | 0.12M | 0.70M | ||||||
| Change in Accured Expenses | 0.03M | 0.07M | -0.01M | 0.00M | 0.03M | 0.05M | -0.01M | 0.01M | 0.04M | 0.04M | -0.00M | 0.05M | 0.00M | -0.01M | 0.02M | 0.06M | -0.16M | 0.00M | 0.04M | 0.02M | ||||||
| Other Working Capital Changes | 0.55M | -0.22M | -0.17M | 0.40M | 0.40M | -0.71M | -0.14M | -0.20M | 0.41M | -0.10M | -0.07M | 0.02M | 0.26M | -0.16M | 0.20M | |||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 0.01M | -0.14M | 0.01M | 0.00M | 0.01M | |||||||||||||||||||||
| Sales of Property, Plant and Equipment | ||||||||||||||||||||||||||
| Cash from Investing Activities | -0.01M | 0.14M | -0.01M | -0.18M | -0.01M | -0.01M | -0.01M | |||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.00M | 14.25M | ||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.00M | 12.67M | 16.02M | 27.92M | 0.04M | 40.07M | 21.66M | 17.87M | 28.41M | 2.54M | 98.23M | |||||||||||||||
| Exchange Rate Effect | -0.02M | 0.13M | 0.24M | -0.05M | -0.28M | 0.30M | 0.50M | -0.15M | 0.04M | 0.02M | 0.04M | -0.16M | 0.12M | -0.01M | -0.10M | 0.28M | -0.02M | -0.12M | 0.09M | -0.13M | ||||||
| Change in Cash | -2.02M | 7.78M | -4.04M | -3.40M | -3.70M | -4.57M | 12.47M | -6.00M | -3.99M | -4.08M | 23.39M | -5.49M | -6.23M | 36.77M | 16.98M | 10.44M | 25.30M | -5.79M | -3.27M | 94.31M | ||||||
| Free Cash Flow | -2.02M | -4.99M | -4.30M | -3.32M | -3.42M | -4.87M | -4.04M | -5.86M | -4.02M | -4.10M | -4.60M | -5.34M | -6.17M | -3.29M | -4.60M | -7.70M | -3.11M | -8.20M | -3.40M | -3.73M | ||||||
| Net Cash Flow | -2.01M | 7.68M | -4.30M | -3.32M | -3.42M | -4.87M | 11.97M | -5.86M | -4.02M | -4.09M | 23.32M | -5.30M | -6.35M | 36.78M | 17.06M | 10.16M | 25.31M | -5.66M | -3.40M | 94.49M |